The FDA’s gag rule on off-label treatments
Michael Cannon of the Cato Institute talks about restrictions on discussing legal uses of drugs for off-label purposes.
Michael Cannon of the Cato Institute talks about restrictions on discussing legal uses of drugs for off-label purposes.